Andromed (CC:AD) Release: Positive Results with Androflo(TM)
10/19/2005 5:11:01 PM
Andromed Inc. (TSX Venture Exchange: AD), an innovative medical technology company, announces that the results from a clinical study on its non-invasive respiratory monitor, Androflo(TM), were positive. Androflo(TM) is a non-invasive system that converts tracheal sounds detected on a patient's throat using Andromed's Androsonix(TM) acoustic biosensor into estimates of respiratory rate (RR) and other ventilation parameters.
comments powered by